Actblue (SZ:300816) Zheng Quan Ri Bao·2026-02-02 08:13Group 1 - The company has established and launched an AI intelligent agent platform for the medical industry, generating revenue from this business [1] - The company is building a medical health knowledge dissemination system, focusing on core functions such as medical knowledge updates, professional development education, and doctor community interaction [1] - The company aims to provide diversified services to hospitals and pharmaceutical companies, extending from "doctor services" to "industry empowerment" [1] Group 2 - The company's wholly-owned subsidiary, Xihe Chaozhi (Shanghai) Cloud Computing Technology Co., Ltd., has invested in Shanghai Yijian Cloud Computing Technology Co., Ltd., which focuses on the intelligent transformation of healthcare [3] - The subsidiary is dedicated to providing comprehensive solutions for medical institutions and health industry clients, including infrastructure construction, scenario-based applications, data intelligence analysis, and intelligent AI Agent [3]